DS Shulman, SB Whittle, D Surdez, KM Bailey… - NPJ precision …, 2022 - nature.com
The advent of dose intensified interval compressed therapy has improved event-free survival for patients with localized Ewing sarcoma (EwS) to 78% at 5 years. However, nearly a …
Fusion-transcription factors (fusion-TFs) represent a class of driver oncoproteins that are difficult to therapeutically target. Recently, protein degradation has emerged as a strategy to …
Transcription factors (TFs) are frequently mutated in cancer. Paediatric cancers exhibit few mutations genome-wide but frequently harbour sentinel mutations that affect TFs, which …
The EWS-FLI1 fusion oncoprotein deregulates transcription to initiate the paediatric cancer Ewing sarcoma. Here we used a domain-focused CRISPR screen to implicate the …
JA Shields, SR Meier, M Bandi, EE Mulkearns-Hubert… - Cancer Research, 2022 - AACR
Synthetic lethality is a genetic interaction that results in cell death when two genetic deficiencies co-occur but not when either deficiency occurs alone, which can be co-opted for …
C Lu, A Mahajan, SH Hong, S Galli, S Zhu… - Nature …, 2022 - nature.com
Adverse prognosis in Ewing sarcoma (ES) is associated with the presence of metastases, particularly in bone, tumor hypoxia and chromosomal instability (CIN). Yet, a mechanistic …
JA Horsfield - The FEBS journal, 2023 - Wiley Online Library
The cohesin complex has a range of crucial functions in the cell. Cohesin is essential for mediating chromatid cohesion during mitosis, for repair of double‐strand DNA breaks, and …
DS Shulman, S Chen, D Hall, A Nag… - British Journal of …, 2022 - nature.com
Background Ewing sarcoma (EWS) is an aggressive sarcoma with no validated molecular biomarkers. We aimed to determine the frequency of STAG2 protein loss by …
IA Showpnil, J Selich-Anderson, C Taslim… - Nucleic Acids …, 2022 - academic.oup.com
Ewing sarcoma is a prototypical fusion transcription factor-associated pediatric cancer that expresses EWS/FLI or a highly related FET/ETS chimera. EWS/FLI dysregulates …